logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Reshape raised $20M in a Series A round of funding to scale its technology in the U.S. for automating lab experiments.

Apr 09, 2024over 1 year ago

Amount Raised

$20 Million

Round Type

series a

CopenhagenMachine LearningBiotechnologySoftware

Description

Reshape, a Danish startup, has raised $20 million in a Series A round of funding to scale its technology in the U.S. The company aims to automate lab experiments that involve visual inspections using a robotic imaging system replete with software and AI models.

Company Information

Company

Reshape

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals. We’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech